文献速递先天性心脏病外科心外重症与机械循环支持

儿童医院Fontan患者联合心肝移植结局分析

Outcomes of Fontan patients undergoing combined heart-liver transplantation in pediatric hospitals across the United States.
PubMed 文献 · J Thorac Cardiovasc Surg · 2025-08-14

本研究基于美国儿童医院数据库合并数据,回顾2010至2024年34例Fontan术后联合心肝移植(CHLT)患儿,82%在2019年后完成,中位年龄19岁。

要点

  • Fontan患者CHLT数量近年快速增加,多在小儿年龄段后完成。
  • CHLT后总体1年生存率85%,死亡均发生在出院前及移植后6个月内。

核心结论

  • 儿童医院Fontan术后CHLT数量快速增加,出院后长期生存优异,3年生存率与单纯心脏移植相似。

研究设计与样本

  • 回顾性队列研究,合并儿童健康信息系统与器官共享网络数据,纳入2010至2024年9家儿童医院34例Fontan CHLT患者,并与Fontan单纯心脏移植按2:1匹配。

主要发现

  • 34例CHLT中82%(n=28)在2019年后完成,47%(n=16)年龄≤18岁,中位年龄19岁(四分位距15-24岁)。
  • 68%为左心发育不良综合征,38%为双入口左心室,26%为右室双出口,18%为三尖瓣闭锁。
  • 总体1年生存率85%,>18岁者94%,≤18岁者75%;死亡均发生于出院前及移植后6个月内,平均随访4年。

临床怎么用

  • Fontan相关肝病患者可考虑CHLT,尤其存活出院后长期预后良好。
  • CHLT与单纯心脏移植3年生存率无显著差异,选择策略需综合评估。

局限性

  • 样本量小(34例),仅来自9家儿童医院,回顾性设计,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: With increasing numbers of patients surviving Fontan palliation, there is a rise in Fontan-associated liver disease and transplantation strategies inclusive of combined heart-liver transplantation (CHLT). Therefore, we reviewed a combined dataset assessing outcomes of pediatric patients undergoing CHLT. METHODS: Patients undergoing Fontan CHLT between 2010 and 2024 at pediatric hospitals were queried from a merged dataset of the Pediatric Health Information System and United Network for Organ Sharing. Matching (2:1) was completed with Fontan heart-only transplant recipients. RESULTS: A total of 34 patients underwent Fontan CHLT at 9 pediatric hospitals between 2010 and 2024, 82% (n = 28) after 2019. Almost one-half (47%; n = 16) were age ≤18 years at the time of CHLT, with a median age of 19 years (interquartile range, 15-24 years). More than two-thirds (68%) had hypoplastic left heart syndrome, 38% had double-inlet left ventricle, 26% had double-outlet right ventricle, and 18% had tricuspid atresia. One-third of the patients (n = 11) had a Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease score of ≤10 at CHLT, with 91% hospital survival, and those with a score >10 had 82% survival. One-year survival was 85% overall, 94% for those age >18 years, and 75% for those age ≤18 years. All deaths occurred before hospital discharge and within 6 months of transplantation, with a mean follow-up of 4 years. Three-year survival was similar in the CHLT and heart transplant -only (HT) groups (85% vs 84%; P = .96, log-rank test). CONCLUSIONS: This multi-institutional analysis demonstrates the rapidly increasing numbers of Fontan palliated patients successfully undergoing CHLT in pediatric hospitals. Conditional on surviving to discharge, long-term survival has been excellent, demonstrating a success story in transplantation management for this complex population.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Chappell G, Mehdizadeh-Shrifi A, Turner D, et al. Outcomes of Fontan patients undergoing combined heart-liver transplantation in pediatric hospitals across the United States. J Thorac Cardiovasc Surg. 2025. PMID: 40818789. doi:10.1016/j.jtcvs.2025.08.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。